Please use these boxes to provide up to 2 drivers of HIGH importance. Click on HELP to see examples:
|
Driver 1
|
Driver 2
|
Economic
|
The reason for the attractiveness of China as a research location for biotech is mainly an enormous cost advantage. The relatively low expenditures on clinical tests and the availability of high-skilled scientists such as chemists, biologists and pharmaceutical chemists, whose initial salary levels are way below the standard in the EU and the United States, might lead to a further settlement of international pharmaceutical companies in China and a clustering of biotechnological skills and know-how.
|
|
Political
|
Particularly beneficial regulations concerning the conduction of genetic assays or fiscal benefits, such as reduced tax rates or even exemptions for high-tech companies might further attract international companies to conduct pharmaceutical research in China.
|
|